CoChat

Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States

Matsuzaki, Shinya, Mandelbaum, Rachel S., Sangara, Rauvynne N., McCarthy, Lauren E., Vestal, Nicole L., Klar, Maximilian, Matsushima, Kazuhide, Amaya, Rodolfo, Ouzounian, Joseph G., Matsuo, Koji · 2021 · American Journal of Obstetrics and Gynecology
Cited by 213

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

BACKGROUND Although an infrequent occurrence, the placenta can adhere abnormally to the gravid uterus leading to significantly high maternal morbidity and mortality during cesarean section (CS). Contemporary national statistics related to a morbidly adherent placenta, referred to as placenta accreta spectrum (PAS), are needed. OBJECTIVE To examine national trends, characteristics, and perioperative outcomes of women who underwent CS for PAS in the United States. METHODS This is a population-based retrospective, observational study querying the National Inpatient Sample. The study cohort included women who underwent CS from 10/2015-12/2017 and had a diagnosis of PAS. The main outcome measures were patient characteristics and surgical outcomes related to PAS assessed by the generalized estimating equation on multivariable analysis. Temporal trend of PAS was also assessed by linear segmented regression with log transformation. RESULTS Of 2,727,477 cases that underwent CS during the study period, 8,030 (0.29%) had the diagnosis of PAS. Placenta accreta was the most common diagnosis (n=6,205, 0.23%), followed by percreta (n=1,060, 0.04%) and increta (n=765, 0.03%). The number of PAS cases increased by 2.1% every quarter-year from 0.27% to 0.32% (P=0.004). On multivariable analysis, (i) patient demographics: older age, tobacco use, recent diagnosis, higher comorbidity, and use of assisted reproductive technology, (ii) pregnancy characteristics: placenta previa, prior CS, breech presentation, and grand multiparity, and (iii) hospital factors: urban-teaching center and large bed capacity hospital, represented the independent characteristics related to PAS (all, P<0.05). The median gestational age at CS was 36 weeks for placenta accreta, and 34 weeks for both placenta increta and percreta versus 39 weeks for non-PAS cases (P<0.001). On multivariable analysis, CS complicated by PAS was associated with increased risk of: any surgical morbidities (78.3% versus 10.6%), CDC-defined severe maternal morbidity (60.3% versus 3.1%), hemorrhage (54.1% versus 3.9%), coagulopathy (5.3% versus 0.3%), shock (5.0% versus 0.1%), urinary tract injury (8.3% versus 0.2%), and death (0.25% versus 0.01%) compared to CS without PAS. When further analyzed by subtype, CS for placenta increta and percreta was associated with higher likelihood of hysterectomy (0.4% for non-PAS, 45.8% for accreta, 82.4% for increta, 78.3% for percreta, P<0.001) and urinary tract injury (0.2% for non-PAS, 5.2% for accreta, 11.8% for increta, 24.5% for percreta, P<0.001). Moreover, women in the placenta increta and percreta groups had markedly increased risks of surgical mortality compared to those without PAS (increta, odds ratio 19.9; and percreta, odds ratio 32.1). CONCLUSION Patient characteristics and outcomes differ across the PAS subtypes and women with placenta increta and percreta have considerably high surgical morbidity and mortality risks. One in 313 women undergoing CS had a diagnosis of PAS by the end of 2017 and the incidence appears to be higher than reported in previous studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajog.2021.04.233

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 33

  1. Burton, 2015, What is the placenta?, Am J Obstet Gynecol, 213, 10.1016/j.ajog.2015.07.050 · DOI · Paper page
  2. Jauniaux, 2020, A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta, Am J Obstet Gynecol, 222, 379.e1, 10.1016/j.ajog.2019.11.1246 · DOI · Paper page
  3. Matsuzaki, 2018, Conservative management of placenta percreta, Int J Gynaecol Obstet, 140, 299, 10.1002/ijgo.12411 · DOI
  4. Licon, 2020, Implementation of multidisciplinary practice change to improve outcomes for women with placenta accreta spectrum, Eur J Obstet Gynecol Reprod Biol, 246, 194, 10.1016/j.ejogrb.2020.01.010 · DOI
  5. 2018, Obstetric Care Consensus No. 7: placenta accreta spectrum, Obstet Gynecol, 132, e259, 10.1097/AOG.0000000000002983 · DOI · Paper page
  6. Read, 1980, Placenta accreta: changing clinical aspects and outcome, Obstet Gynecol, 56, 31
  7. Miller, 1997, Clinical risk factors for placenta previa-placenta accreta, Am J Obstet Gynecol, 177, 210, 10.1016/S0002-9378(97)70463-0 · DOI · Paper page
  8. Thurn, 2016, Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries, BJOG, 123, 1348, 10.1111/1471-0528.13547 · DOI · Paper page
  9. Thurn, 2019, Massive blood transfusion in relation to delivery: incidence, trends and risk factors: a population-based cohort study, BJOG, 126, 1577, 10.1111/1471-0528.15927 · DOI
  10. Marcellin, 2018, Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta, Am J Obstet Gynecol, 219, 193.e1, 10.1016/j.ajog.2018.04.049 · DOI · Paper page
  11. Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 · DOI · Paper page
  12. Mandelbaum, 2020, Conservative surgery for ovarian torsion in young women: perioperative complications and national trends, BJOG, 127, 957, 10.1111/1471-0528.16179 · DOI
  13. Matsuo, 2021, National trends and outcomes of morbidly obese women who underwent inpatient hysterectomy for benign gynecological disease in the USA, Acta Obstet Gynecol Scand, 100, 459, 10.1111/aogs.14034 · DOI
  14. Kim, 2000, Permutation tests for joinpoint regression with applications to cancer rates, Stat Med, 19, 335, 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z · DOI · Paper page
  15. Zeger, 1988, Models for longitudinal data: a generalized estimating equation approach, Biometrics, 44, 1049, 10.2307/2531734 · DOI · Paper page
  16. Greenland, 2016, Outcome modelling strategies in epidemiology: traditional methods and basic alternatives, Int J Epidemiol, 45, 565, 10.1093/ije/dyw040 · DOI · Paper page
  17. Pavlou, 2016, Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events, Stat Med, 35, 1159, 10.1002/sim.6782 · DOI · Paper page
  18. Mandelbaum, 2020, The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States, Am J Obstet Gynecol, 223, 721.e1, 10.1016/j.ajog.2020.04.028 · doi:10.1016/j.ajog.2020.04.028
  19. von Elm, 2007, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, BMJ, 335, 806, 10.1136/bmj.39335.541782.AD · DOI · Paper page
  20. Baldwin, 2017, Maternal and neonatal outcomes following abnormally invasive placenta: a population-based record linkage study, Acta Obstet Gynecol Scand, 96, 1373, 10.1111/aogs.13201 · DOI · Paper page
  21. Martin, 2019, Births: final data for 2018, Natl Vital Stat Rep, 68, 1
  22. Einerson, 2020, Placenta accreta spectrum disorder: uterine dehiscence, not placental invasion, Obstet Gynecol, 135, 1104, 10.1097/AOG.0000000000003793 · DOI · Paper page
  23. Kyozuka, 2019, Risk factors for placenta accreta spectrum: findings from the Japan environment and children’s study, BMC Pregnancy Childbirth, 19, 447, 10.1186/s12884-019-2608-9 · DOI
  24. Iacovelli, 2020, Risk factors for abnormally invasive placenta: a systematic review and meta-analysis, J Matern Fetal Neonatal Med, 33, 471, 10.1080/14767058.2018.1493453 · DOI · Paper page
  25. Miller, 2021, Placenta accreta spectrum among women with twin gestations, Obstet Gynecol, 137, 132, 10.1097/AOG.0000000000004204 · DOI
  26. Clark, 2008, Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery, Am J Obstet Gynecol, 199, 36.e1, 10.1016/j.ajog.2008.03.007 · DOI · Paper page
  27. Kingdom, 2020, Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020, Am J Obstet Gynecol, 223, 322, 10.1016/j.ajog.2020.01.044 · DOI
  28. Carusi, 2020, Placenta accreta spectrum without placenta previa, Obstet Gynecol, 136, 458, 10.1097/AOG.0000000000003970 · DOI
  29. Buca, 2018, Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis, Ultrasound Obstet Gynecol, 52, 304, 10.1002/uog.19070 · DOI · Paper page
  30. Jotwani, 2021, Positive predictive value of ICD-10 codes for placenta accreta syndrome: a single center validation study, Am J Obstet Gynecol, 224, S523, 10.1016/j.ajog.2020.12.865 · doi:10.1016/j.ajog.2020.12.865
  31. Couret, 2019, Patterns of care for women with placenta accreta spectrum, J Matern Fetal Neonatal Med
  32. Erfani, 2019, Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team, Am J Obstet Gynecol, 221, 337.e1, 10.1016/j.ajog.2019.05.035 · DOI
  33. Silver, 2015, Center of excellence for placenta accreta, Am J Obstet Gynecol, 212, 561, 10.1016/j.ajog.2014.11.018 · DOI · Paper page

Cited by

See all 213

Metadata

Authors
Matsuzaki, S., Mandelbaum, R. S., Sangara, R. N., McCarthy, L. E., Vestal, N. L., Klar, M., Matsushima, K., Amaya, R., Ouzounian, J. G., & Matsuo, K.
Venue
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Published
2021-11
Volume
225
Issue
5
Pages
534.e1-534.e38
ISSN
0002-9378 (ISSN-L)
OpenAlex
W3155964117
Cited by
213
References
14
FWCI
29.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States. https://app.cochat.ai/papers/10.1016/j.ajog.2021.04.233
The paper
Matsuzaki, S., Mandelbaum, R. S., Sangara, R. N., McCarthy, L. E., Vestal, N. L., Klar, M., Matsushima, K., Amaya, R., Ouzounian, J. G., & Matsuo, K. (2021). Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2021.04.233

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.